期刊文献+

竞争性内源RNA在胃癌发生发展中的作用 被引量:2

Role of competing endogenous RNAs in development of gastric cancer
下载PDF
导出
摘要 胃癌是常见的消化系肿瘤之一,在全球癌症死亡中排名第2位.其发病与遗传、环境及生活习惯等多种因素有关.近几年研究发现竞争性内源RNA成员中微小RNA和长链非编码RNA在胃癌的发生发展起着重要作用.本文就竞争性内源RNA在胃癌中作用作一综述. Gastric cancer is one of the most common digestive system tumors and the second cause of malignancy related death, and it is caused by multiple factors such as genetic susceptibility,environment and living habits. It is reported that members of competitive endogenous RNAs, including microRNAs and long noncoding RNAs, play an important role in gastric cancer development. This article reviews the role of competing endogenous RNAs in the development of gastric cancer.
出处 《世界华人消化杂志》 CAS 2016年第11期1676-1681,共6页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.81573760 浙江省自然科学基金资助项目 No.Y16H030033~~
关键词 竞争性内源RNA 微小RNA 长链非编码RNA 环状RNA 胃癌 Competing endogenous RNAs MicroRNAs Long non-coding RNAs Circular RNAs Gastric cancer
  • 相关文献

参考文献49

  • 1Yoon H, Kim N. Diagnosis and management of high risk group for gastric Cancer. Gut Liver 2015; 9:5-17.
  • 2Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, Xiao B, Guo J. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014; 35:5441-5447 [PMID: 24523021 DOI: 10.1007/ s13277-014-1709-3].
  • 3Ishihara R. Infrared endoscopy in the diagnosis and treatment of early gastric cancer. Endoscopy 2010; 42:672-676 [PMID: 20486079 DOI: 10.1055/ s-0029-1244205].
  • 4Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 2010; 14: 302-308 [PMID: 20496539].
  • 5Krejs GJ. Gastric cancer: epidemiology and risk factors. Dig Dis 2010; 28:600-603 [PMID: 21088409 DOI: 10.1159/000320277].
  • 6Song HR, Kweon SS, Kim HN, Piao JM, Yun W'J, Choi JS, Hwang JE, Yoon JY, Kim HR, Park YK, Kim SH, Choi YD, Shin MH. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer 2011; 14:242-248 [PMID: 21461655 DOI: 10.1007/s10120-011-0034-4].
  • 7Shirai O, Ohmiya N, Taguchi A, Nakamura M, Kawashima H, Miyahara R, Itoh A, Hirooka Y, Watanabe O, Ando T, Goto Y, Hamajima N, Goto H. P53, p21, and p73 gene polymorphisms in gastric carcinoma. Hepatogastroenterology 2010; 57: 1595-1601 [PMID: 21443127].
  • 8Cooper CS, Foster CS. Concepts of epigenetics in prostate cancer development. Br J Cancer 2009; 100:240-245 [PMID: 19002169 DOI: 10.1038/ sj.~c.6604771].
  • 9Xu Z, Zhu H, Luk JM, Wu D, Gu D, Gong W, Tan Y, Zhou J, Tang J, Zhang Z, Wang M, Chen J. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer 2012; 118:5489-5496 [PMID: 22517484 DOI: 10.1002/cncr.27599].
  • 10Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12:354-362 [PMID: 16489633].

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部